Abstract:Abstract BackgroundEMT confers increased metastatic potential andtheresistance to chemotherapiesto cancer cells.However, the precise mechanisms of EMT-related chemotherapy resistance remain unclear.MethodsAnticancer effects were determined by MTT, soft agar, cell cycle, propidium iodide and Annexin V analysis. The effect of drugs on tumor growth was assessed using patient-derived xenograft model and nude mice model.Morphology of tumor cells were observed by phase contrast microscopy. Proteins interactions were tested by western blot and coimmunoprecipitation. Immunohistochemistry and LNA ISH were performed to determine protein and lncRNA expression. Candidate lncRNA was screened out by microarray.Resultsc-Src-mediated Caspase-8 phosphorylationessential for EMT in lung adenocarcinoma cell linespreferentially occurs in cells with themesenchymal phenotype,resultingin chemoresistance tocisplatin plus paclitaxel in patients with resectable lung adenocarcinoma and a significantly worse5-yearPFS. Cisplatin killedlung adenocarcinoma cells regardless of Caspase-8. Paclitaxel-triggered necroptosis in lung adenocarcinoma cells was dependent on the phosphorylation or deficiency ofCaspase-8, during which FADDinteracted with RIPK1 to activateRIPK1/RIPK3/MLKL signaling axis. Accompanied with c-Src-mediated Caspase-8 phosphorylation to trigger EMT, a novel lncRNA named lncCRLA was markedly upregulated andinhibited RIPK1-induced necroptosis byimpairingRIPK1-RIPK3 interaction via binding to the intermediate domain of RIPK1. Dasatinibmitigatedc-Src-mediated phosphorylationof Caspase-8-induced EMT and enhanced necroptosis in mesenchymal-like lung adenocarcinoma cells treated with paclitaxel, while c-FLIP knockdown predominantly sensitized the mesenchymal-like lung adenocarcinoma cells to paclitaxel+dasatinib.Conclusionsc-Src-Caspase-8 interaction initiatesEMT and chemoresistance viaCaspase-8 phosphorylation and lncCRLA expression, to which the dasatinib/paclitaxel liposome+siFLIPregimen was lethal.

NLR family CARD domain containing 5 promotes hypoxia-induced cancer progress and carboplatin resistance by activating PI3K/AKT via carcinoembryonic antigen related cell adhesion molecule 1 in non-small cell lung cancer

NLRC5 promotes tumorigenesis by regulating the PI3K/AKT signaling pathway in cervical cancer

Long Non-Coding RNA BC087858 Induces Non-T790m Mutation Acquired Resistance to EGFR-TKIs by Activating PI3K/AKT and MEK/ERK Pathways and EMT in Non-Small-cell Lung Cancer

Interplay Of Mkp-1 And Nrf2 Drives Tumor Growth And Drug Resistance In Non-Small Cell Lung Cancer

Human RECQL5 promotes metastasis and resistance to cisplatin in non-small cell lung cancer

ERO1L promotes NSCLC development by modulating cell cycle‐related molecules

CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway.

Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog

NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer

lncCRLA Enhanced&nbsp;Chemoresistance in Lung Adenocarcinoma That Underwentepithelial-mesenchymal Transition

UNC5A, an epigenetically silenced gene, functions as a tumor suppressor in non-small cell lung cancer

NLRC5 Might Promote Endometrial Cancer Progression by Inducing PD-L1 Expression

CXCL5 Regulation of Proliferation and Migration in Human Non-Small Cell Lung Cancer Cells

Neurokinin-1 Receptor Promotes Non-Small Cell Lung Cancer Progression Through Transactivation of EGFR.

A Critical Role for the Long Non‐coding RNA GAS5 in Proliferation and Apoptosis in Non‐small‐cell Lung Cancer

NCOA5 promotes proliferation, migration and invasion of colorectal cancer cells via activation of PI3K/AKT pathway.

Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway

NLRC5 promotes endometrial carcinoma progression by regulating NF-κB pathway-mediated mismatch repair gene deficiency

NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling

Extracellular signal-regulated kinase 5 increases radioresistance of lung cancer cells by enhancing the DNA damage response

PPIP5K2 Facilitates Proliferation and Metastasis of Non-Small Lung Cancer (NSCLC) through AKT Signaling Pathway